Influence of GST Gene Polymorphisms on the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sung-Doo | - |
dc.contributor.author | Lee, Je-Hwan | - |
dc.contributor.author | Nur, Eun-Hye | - |
dc.contributor.author | Lee, Jung-Hee | - |
dc.contributor.author | Kim, Dae-Young | - |
dc.contributor.author | Lim, Sung-Nam | - |
dc.contributor.author | Choi, Yunsuk | - |
dc.contributor.author | Lim, Hyeong-Seok | - |
dc.contributor.author | Bae, Kyun-Seop | - |
dc.contributor.author | Noh, Gyu-Jeong | - |
dc.contributor.author | Yun, Sung-Cheol | - |
dc.contributor.author | Han, Sang Beom | - |
dc.contributor.author | Lee, Kyoo-Hyung | - |
dc.date.available | 2019-05-29T11:38:39Z | - |
dc.date.issued | 2011-08 | - |
dc.identifier.issn | 1083-8791 | - |
dc.identifier.issn | 1523-6536 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/21365 | - |
dc.description.abstract | Intravenous (i.v.) busulfan can produce a more consistent pharmacokinetic profile than oral formulations can, but nonetheless, significant interpatient variability is evident. We investigated the influence of polymorphisms of 3 GST isozyme genes (GSTA1, GSTM1, and GSTT1) on i.v. busulfan clearance. Fifty-eight adult patients who received 3.2 mg/kg/day of busulfan as conditioning for hematopoietic cell transplantation were included in this study. Stepwise multiple linear regression demonstrated that GSTA1 variant GSTA1*B (P = .004), GSTM1/GSTT1 double-null genotype (P = .039), and actual body weight (P = .001) were significantly associated with lower clearance of i.v. busulfan. A trend test analyzing the overall effect of GST genotype on busulfan pharmacokinetics, combining GSTA I gene polymorphism and the number of GSTM1- and GSTT-null genotypes, showed a significant correlation between GST genotype and busulfan clearance (P = .001). The clearance of i.v. busulfan was similar between patients with GSTA1*A/*A and GSTM1/GSTT1 double-null genotypes and those with GSTA1*A/*B and GSTM1/GSTT1 double-positive genotypes. In conclusion, a pharmacogenetic approach using GST gene polymorphisms may be valuable in optimizing the i.v. busulfan dosage scheme. Our results also highlight the importance of including polygenic analyses and addressing interactions among isozyme genes in pharmacogenetic studies. Biol Blood Marrow Transplant 17: 1222-1230 (2011) (C) 2011 American Society for Blood and Marrow Transplantation | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Influence of GST Gene Polymorphisms on the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bbmt.2010.12.708 | - |
dc.identifier.bibliographicCitation | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, v.17, no.8, pp 1222 - 1230 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000293429600015 | - |
dc.identifier.scopusid | 2-s2.0-79960283058 | - |
dc.citation.endPage | 1230 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1222 | - |
dc.citation.title | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - |
dc.citation.volume | 17 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | Hematopoietic cell transplantation | - |
dc.subject.keywordAuthor | Busulfan | - |
dc.subject.keywordAuthor | Pharmacokinetics | - |
dc.subject.keywordAuthor | Glutathione S-Transferase | - |
dc.subject.keywordAuthor | Pharmacogenetics | - |
dc.subject.keywordPlus | BONE-MARROW TRANSPLANTATION | - |
dc.subject.keywordPlus | S-TRANSFERASE A1 | - |
dc.subject.keywordPlus | TOTAL-BODY IRRADIATION | - |
dc.subject.keywordPlus | ACUTE MYELOID-LEUKEMIA | - |
dc.subject.keywordPlus | GLUTATHIONE CONJUGATION | - |
dc.subject.keywordPlus | CANCER SUSCEPTIBILITY | - |
dc.subject.keywordPlus | CONDITIONING THERAPY | - |
dc.subject.keywordPlus | NULL GENOTYPES | - |
dc.subject.keywordPlus | HOST DISEASE | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.